Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Sumitomo Pharma America, Inc.
Primary Objective: • To establish the MTD and/or Recommended Phase 2 Dose (RP2D) of orally administered TP-1454 in patients with metastatic solid tumors and anal cancer. Secondary Objectives: * To establish the pharmacokinetic (PK) profile of orally administered TP-1454 * To observe patients for any evidence of antitumor activity of TP 1454 by objective radiographic assessment * To assess the safety and tolerability of TP-1454
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted